Analyst Ratings for Cara Therapeutics (CARA) [Buys]

CARA Rating Summary

CARA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CARA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $24.60 (+83%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 84%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/6/2019 Jefferies
» Updated 4/29/2021
Roger Song New Coverage Buy
(N/A)
23.00
(47.00)
15.37
(13.44)
-12.56% Details
12/20/2018 Janney
» Updated 5/29/2019
Esther Hong New Coverage Buy
(N/A)
33.00
(27.00)
13.80
(13.44)
-2.61% Details
Like CARA Ratings? Also take a look at SWKH, MTSC, APH, CRIS

CARA Ratings News